Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

A Krämer; T Bochtler; C Pauli; G Baciarello; S Delorme; K Hemminki; L Mileshkin; H Moch; K Oien; T Olivier; A Patrikidou; H Wasan; G Zarkavelis; G Pentheroudakis; K Fizazi; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org

doi:10.1016/j.annonc.2022.11.013

Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Ann Oncol. 2023 Mar;34(3):228-246. doi: 10.1016/j.annonc.2022.11.013. Epub 2022 Dec 20.

Authors

A Krämer¹, T Bochtler², C Pauli³, G Baciarello⁴, S Delorme⁵, K Hemminki⁶, L Mileshkin⁷, H Moch³, K Oien⁸, T Olivier⁹, A Patrikidou¹⁰, H Wasan¹¹, G Zarkavelis¹², G Pentheroudakis¹³, K Fizazi¹⁰; ESMO Guidelines Committee. Electronic address: [email protected]

Affiliations

¹ Clinical Cooperation Unit Molecular Haematology/Oncology, German Cancer Research Center (DKFZ) Heidelberg, Germany; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
² Clinical Cooperation Unit Molecular Haematology/Oncology, German Cancer Research Center (DKFZ) Heidelberg, Germany; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany; Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany.
³ Department of Pathology and Molecular Pathology, University Hospital Zurich (USZ), Zurich, Switzerland; Medical Faculty, University of Zurich (UZH), Zurich, Switzerland.
⁴ Medical Oncology Department, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy.
⁵ Division of Radiology, German Cancer Research Center (DKFZ), Heidelberg.
⁶ Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and Biomedical Center, Charles University, Pilsen, Czech Republic.
⁷ Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
⁸ Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
⁹ Department of Oncology, Geneva University Hospital, Geneva, Switzerland; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, USA.
¹⁰ Department of Cancer Medicine, Institute Gustave Roussy, University of Paris Saclay, Villejuif, France.
¹¹ Department of Cancer Medicine, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
¹² Department of Medical Oncology, University of Ioannina, Ioannina, Greece.
¹³ European Society for Medical Oncology, Lugano, Switzerland.

PMID: 36563965
DOI: 10.1016/j.annonc.2022.11.013

No abstract available

Keywords: Classification; ESMO Clinical Practice Guideline; diagnosis; risk assessment; treatment; unknown primary neoplasm.

Publication types

Practice Guideline
Research Support, Non-U.S. Gov't

MeSH terms

Follow-Up Studies
Humans
Neoplasm Staging
Neoplasms, Unknown Primary* / pathology